Metropolis Healthcare Ltd.

NSE: METROPOLIS | BSE: 542650 | ISIN: INE112L01020 | Industry: Healthcare Services
| Weak Stock
434.4000 3.65 (0.85%)
NSE Apr 07, 2026 15:31 PM
Volume: 175.0K
 

434.40
0.85%
ICICI Securities Limited
Metropolis’ Q1FY24 revenue growth (-1%) and EBITDA margin (-180bps) were impacted by discontinuation of a PPP contract (Q1FY23 sales of INR 200mn) while the core business grew 12% YoY. Metropolis remains committed to expand its network by: 1) deepening its presence in existing cities and venturing into newer ones, 2) connecting directly with consumers to increase B2C share, 3) M&As to improvise scale and restore margins to pre-covid levels.
Metropolis Healthcare Ltd. is trading below all available SMAs
More from Metropolis Healthcare Ltd.
Recommended